Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVACARE CORPORATION

(IVC)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 09/24 11:22:24 am
5.21 USD   -2.80%
09/14INVACARE : Baird Healthcare Conference Presentation – 09.14.21
PU
09/10INVACARE : Needham & Co Adjusts Invacare PT to $8 From $17, Maintains Buy Rating
MT
09/09Top Midday Decliners
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Invacare Corporation : to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results

07/26/2021 | 08:04am EDT

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the second quarter 2021, after the market closes on Wednesday, August 4, 2021. The company will provide a live conference call and webcast to discuss these financial results on Thursday, August 5, 2021 at 8:30 AM ET.

Investors and other interested parties may access the conference call and webcast in the following ways:

About Invacare Corporation

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.


ę Business Wire 2021
All news about INVACARE CORPORATION
09/14INVACARE : Baird Healthcare Conference Presentation – 09.14.21
PU
09/10INVACARE : Needham & Co Adjusts Invacare PT to $8 From $17, Maintains Buy Rating
MT
09/09Top Midday Decliners
MT
09/09INVACARE : I.R. Presentation – 09.09.21
PU
09/09INVACARE : PROVIDES BUSINESS UPDATE AND REVISED FINANCIAL GUIDANCE (Form 8-K)
PU
09/09INVACARE CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/09INVACARE CORPORATION : Provides Business Update and Revised Financial Guidance
BU
09/09Invacare Corporation Provides Sales Guidance for the Third Quarter and Full Year 2021
CI
09/03INVACARE CORP : Change in Directors or Principal Officers (form 8-K)
AQ
09/03Invacare Corporation Announces Executive Changes
CI
More news
Analyst Recommendations on INVACARE CORPORATION
More recommendations
Financials (USD)
Sales 2021 881 M - -
Net income 2021 -30,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,07x
Yield 2021 -
Capitalization 188 M 188 M -
Capi. / Sales 2021 0,21x
Capi. / Sales 2022 0,20x
Nbr of Employees 3 400
Free-Float 83,8%
Chart INVACARE CORPORATION
Duration : Period :
Invacare Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVACARE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 5,36 $
Average target price 9,67 $
Spread / Average Target 80,3%
EPS Revisions
Managers and Directors
Matthew E. Monaghan Chairman, President & Chief Executive Officer
Kathleen Patricia Leneghan Senior VP, Chief Financial & Accounting Officer
Angie Goodwin Chief Technology & Information Officer
Anthony C. LaPlaca Secretary, Chief Administrative Officer & SVP
C. Martin Harris Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INVACARE CORPORATION-36.31%188
ABBOTT LABORATORIES14.44%222 134
MEDTRONIC PLC11.52%175 817
BECTON, DICKINSON AND COMPANY1.44%72 895
HOYA CORPORATION28.03%61 174
SARTORIUS STEDIM BIOTECH83.38%57 768